A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma

[1]  Xiaogang Wang,et al.  GBP2 as a potential prognostic predictor with immune-related characteristics in glioma , 2022, Frontiers in Genetics.

[2]  Xiaogang Wang,et al.  GBP2 facilitates the progression of glioma via regulation of KIF22/EGFR signaling , 2022, Cell death discovery.

[3]  Hongyan Guo,et al.  Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis , 2022, EBioMedicine.

[4]  Jing Liu,et al.  Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target , 2022, Journal for ImmunoTherapy of Cancer.

[5]  Xiaoying Hu,et al.  The JAK/STAT signaling pathway: from bench to clinic , 2021, Signal Transduction and Targeted Therapy.

[6]  Ryan C. Kalb,et al.  The Large GTPase, GBP-2, Regulates Rho Family GTPases to Inhibit Migration and Invadosome Formation in Breast Cancer Cells , 2021, Cancers.

[7]  Z. Shao,et al.  Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response , 2021, Journal of Hematology & Oncology.

[8]  P. He,et al.  GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma , 2021, PeerJ.

[9]  C. Leslie,et al.  Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. , 2021, Cancer cell.

[10]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[11]  Q. Lan,et al.  GBP5 drives malignancy of glioblastoma via the Src/ERK1/2/MMP3 pathway , 2021, Cell Death & Disease.

[12]  B. Győrffy,et al.  Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis , 2021, Computational and structural biotechnology journal.

[13]  Q. Lan,et al.  GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway , 2020, Oncogene.

[14]  J. O’Shea,et al.  SnapShot: Jak-STAT Signaling II , 2020, Cell.

[15]  B. Dai,et al.  Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients , 2020, Journal for ImmunoTherapy of Cancer.

[16]  Bin Hu,et al.  Guanylate‐binding protein‐2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel‐resistant colorectal cancer cells by interfering Wnt signaling , 2020, Journal of cellular biochemistry.

[17]  C. Barbas,et al.  Mass spectrometry based proteomics and metabolomics in personalized oncology. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[18]  M. Rugge,et al.  PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus , 2019, Cancer medicine.

[19]  K. Tretina,et al.  Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease , 2019, The Journal of experimental medicine.

[20]  R. Shamir,et al.  Multi-omic and multi-view clustering algorithms: review and cancer benchmark , 2018, bioRxiv.

[21]  P. Golstein,et al.  An early history of T cell-mediated cytotoxicity , 2018, Nature Reviews Immunology.

[22]  C. Hutter,et al.  The Cancer Genome Atlas: Creating Lasting Value beyond Its Data , 2018, Cell.

[23]  J. Foekens,et al.  T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression , 2018, Acta Neuropathologica.

[24]  M. M. Dias,et al.  Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer , 2017, BMC Cancer.

[25]  Juan Zhang,et al.  Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion , 2017, Cell Death and Disease.

[26]  Yuka Kanno,et al.  Mechanisms and consequences of Jak–STAT signaling in the immune system , 2017, Nature Immunology.

[27]  Ting Wu,et al.  Tumor microenvironment and therapeutic response. , 2017, Cancer letters.

[28]  Brendan MacLean,et al.  CPTAC Assay Portal: a repository of targeted proteomic assays , 2014, Nature Methods.

[29]  L. Chin,et al.  Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma , 2011, The Journal of experimental medicine.

[30]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[31]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[32]  S. Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[33]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.